Simplex Trading’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-42,495
| Closed | -$169K | – | 9952 |
|
|
2025
Q4 | $149K | Buy |
+42,495
| New | +$145K | ﹤0.01% | 4537 |
|
|
2025
Q3 | – | Sell |
-41,379
| Closed | -$130K | – | 9878 |
|
|
2025
Q2 | $101K | Buy |
+41,379
| New | +$210K | ﹤0.01% | 5231 |
|
|
2025
Q1 | – | Sell |
-6,096
| Closed | -$60.2K | – | 9439 |
|
|
2024
Q4 | $76K | Buy |
6,096
+5,633
| +1,217% | +$84.8K | ﹤0.01% | 5444 |
|
|
2024
Q3 | $8K | Sell |
463
-5,362
| -92% | -$110K | ﹤0.01% | 7360 |
|
|
2024
Q2 | $125K | Buy |
+5,825
| New | +$134K | ﹤0.01% | 5139 |
|
|
2023
Q4 | – | Sell |
-101,928
| Closed | -$2.25M | – | 9637 |
|
|
2023
Q3 | $2.09M | Buy |
+101,928
| New | +$1.85M | ﹤0.01% | 2036 |
|
|
2023
Q2 | – | Sell |
-3,385
| Closed | -$68.4K | – | 9759 |
|
|
2023
Q1 | $57K | Buy |
+3,385
| New | +$66.3K | ﹤0.01% | 5790 |
|
|
2022
Q3 | – | Sell |
-452
| Closed | -$7.05K | – | 10712 |
|
|
2022
Q2 | $6K | Buy |
+452
| New | +$5.39K | ﹤0.01% | 8743 |
|
|
2021
Q2 | – | Sell |
-1,350
| Closed | -$58.6K | – | 10598 |
|
|
2021
Q1 | $59K | Buy |
1,350
+1,030
| +322% | +$56.6K | ﹤0.01% | 6407 |
|
|
2020
Q4 | $17K | Sell |
320
-10,701
| -97% | -$390K | ﹤0.01% | 7085 |
|
|
2020
Q3 | $251K | Buy |
11,021
+2,036
| +23% | +$50.2K | ﹤0.01% | 3821 |
|
|
2020
Q2 | $188K | Sell |
8,985
-309
| -3% | -$5.57K | ﹤0.01% | 4076 |
|
|
2020
Q1 | $129K | Buy |
+9,294
| New | +$184K | ﹤0.01% | 4097 |
|
|
2019
Q3 | – | Sell |
-507
| Closed | -$6.29K | – | 7763 |
|
|
2019
Q2 | $7K | Buy |
+507
| New | +$8.85K | ﹤0.01% | 6304 |
|
|
2018
Q4 | – | Sell |
-4,497
| Closed | -$110K | – | 7658 |
|
|
2018
Q3 | $110K | Buy |
4,497
+2,399
| +114% | +$52K | ﹤0.01% | 4340 |
|
|
2018
Q2 | $41K | Buy |
+2,098
| New | +$39.7K | ﹤0.01% | 5267 |
|
|
2017
Q4 | – | Sell |
-1,360
| Closed | -$13.5K | – | 6548 |
|
|
2017
Q3 | $9K | Buy |
1,360
+224
| +20% | +$1.02K | ﹤0.01% | 3883 |
|
|
2017
Q2 | $8K | Sell |
1,136
-755
| -40% | -$5.63K | ﹤0.01% | 4190 |
|
|
2017
Q1 | $15K | Sell |
1,891
-8,200
| -81% | -$55.1K | ﹤0.01% | 3581 |
|
|
2016
Q4 | $246K | Buy |
10,091
+8,665
| +608% | +$247K | 0.01% | 910 |
|
|
2016
Q3 | $54K | Sell |
1,426
-6,190
| -81% | -$195K | ﹤0.01% | 2035 |
|
|
2016
Q2 | $226K | Buy |
+7,616
| New | +$268K | 0.02% | 915 |
|
Other funds holding RCKT
RI
NM
MC
Simplex Trading's RCKT Position: Q1 2026 in Review
Simplex Trading sold out of Rocket Pharmaceuticals (RCKT) in Q1 2026, closing a stake of 42,495 shares — an estimated $169K sold.
Simplex Trading first reported a position in RCKT in Q2 2016 and held it in 22 quarters. The position peaked at $2.09M in Q3 2023. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.
- Simplex Trading reported no remaining Rocket Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 42,495 Rocket Pharmaceuticals shares in Q1 2026, an estimated $169K.
- Simplex Trading first reported a position in Rocket Pharmaceuticals in Q2 2016 and held it in 22 quarters.
- Simplex Trading's Rocket Pharmaceuticals position peaked at $2.09M in Q3 2023.
- 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.